Health care workers of color are nearly 2 times more likely than their white colleagues to test positive for coronavirus disease 2019; Teladoc Health announced an agreement to acquire Livongo, a diabetes coaching company, for $18.5 billion; the CDC has issued a warning against ingesting alcohol-based hand sanitizer in response to reports of poisonings in the United States.
According to a study by Harvard Medical School and published in The Lancet Public Health, health care workers of color were more likely to care for patients with suspected or confirmed coronavirus disease 2019 (COVID-19), more likely to report inadequate personal protective equipment, and nearly twice as likely as their white colleagues to test positive for COVID-19. Reported by Kaiser Health News, the study also found that health workers are at least 3 times more likely than the general population to report positive COVID-19 results, with health care workers of color having a 5 times greater risk of infection.
Yesterday, telemedicine provider Teladoc Health announced an agreement to acquire Livongo, a diabetes coaching company for $18.5 billion, according to STAT. The merger agreement was indicated to put the combined company on track to bring in $1.3 billion, potentially creating the first health tech giant. Amid the pandemic, stocks for both companies have reached all time highs this week. Compared with the start of 2020, Livongo’s share price is nearly 6 times higher and Teladoc’s is 3 times higher.
The CDC issued a warning yesterday against the ingestion of alcohol-based hand sanitizer in response to reports of poisonings in the United States. As detailed by The Hill, there were 15 reports issued by poison centers in Arizona and New Mexico of methanol poisoning associated with swallowing hand sanitizer between May and June. Of those who were hospitalized, 4 died and 3 were discharged with visual impairment. After a consumer alert on hand sanitizers containing methanol, the CDC received the case reports, which were all tied to those containing the toxic substance.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More